_id
695fb80ec2e91020a7bd4276
Ticker
0I8C.LSE
Name
Aqua Bio Technology ASA
Exchange
LSE
Address
BygdOey AllE 3, Oslo, Norway, 0257
Country
UK
Sector
Industry
Currency
NOK
Website
https://aquabiotechnology.com
Description
Aqua Bio Technology ASA, a biotechnology company, commercializes ingredients for cosmetics in Norway. It offers Aquabeautine XL, a first-generation ingredient for cosmetics; and Spirulysat, an antioxidant and vitamin-boosted spirulina for cosmetic use, as well as has license for Zand Exfoliator. The company also markets skincare products, such as toner, serum, renewal day cream, oil, nourishing cream, night repair serum, night repair complex moisturizer, make-up remover, instant lifting mask, gentle exfoliator, eye firming, and gel cleansing milk under the Moana Skincare brand; serum and moisturizer under the Tau brand name; and protecting balm, oil, lotion, and calming cream under the Moana Baby brand through a network of distributors in Europe, the Middle East, and the Asia Pacific markets. In addition, the company offers askincare products under the seidr, seidr Clinique, and B Natural brands. It distributes its products through Internet, stores, and skincare clinics. Aqua Bio Technology ASA was founded in 2000 and is based in Lysaker, Norway.
Last Close
0.524
Volume
2970
Current Price
0.524
Change
0.0545
Last Updated
2026-01-08T13:58:38.217Z
Ipo Date
-
Market Cap
-
Next Dividend Date
-
Dividend Frequency
-
Dividend Rate
-
Dividend Yield
0
Sentiment
-
Sentiment Sources
0
Current Quarter
2021-06-30
Revenue
-
Cost Of Revenue
-
Gross Profit
-
Operating Expenses
-
Operating Income
-
Interest Expense
-
Pretax Income
-
Net Income
-
Eps
-
Dividends Per Share
-
Shares Outstanding
0
Income Tax Expense
-
EBITDA
-
Operating Margin
-
Total Other Income Expense Net
-
Cash
-
Short Term Investments
-
Receivables
1510015
Inventories
4482304
Total Current Assets
15724321
Property Plant Equipment
432797
Total Assets
-
Payables
2780236
Short Term Debt
-
Long Term Debt
-
Total Liabilities
10692129
Equity
-
Bs_currency_symbol
NOK
Depreciation
227800
Change In Working Capital
-
Cash From Operations
-5552208
Capital Expenditures
0
Cash From Investing
-2702670
Cash From Financing
10406301
Net Change In Cash
2151424
Cf_currency_symbol
NOK
PE
-
PB
-
ROE
-
ROA
-
FCF
-5552208
Fcf Percent
-
Piotroski FScore
0
Health Score
45
Deep Value Investing Score
0
Defensive Investing Score
5
Dividend Investing Score
1.5
Economic Moat Investing Score
1
Garp Investing Score
0
Growth Investing Score
0
Momentum Investing Score
2
Net Net Investing Score
0
Quality Investing Score
0
Value Investing Score
1.5
Quarters > 0 > quarter
2021-06-30
Quarters > 0 > income Statement > revenue
-
Quarters > 0 > income Statement > cost Of Revenue
-
Quarters > 0 > income Statement > gross Profit
-
Quarters > 0 > income Statement > operating Expenses
-
Quarters > 0 > income Statement > operating Income
-
Quarters > 0 > income Statement > interest Expense
-
Quarters > 0 > income Statement > pretax Income
-
Quarters > 0 > income Statement > net Income
-
Quarters > 0 > income Statement > eps
-
Quarters > 0 > income Statement > dividends Per Share
-
Quarters > 0 > income Statement > shares Outstanding
-
Quarters > 0 > income Statement > income Tax Expense
-
Quarters > 0 > income Statement > EBITDA
-
Quarters > 0 > income Statement > operating Margin
-
Quarters > 0 > income Statement > total Other Income Expense Net
-
Quarters > 0 > income Statement > currency_symbol
NOK
Quarters > 0 > balance Sheet > cash
-
Quarters > 0 > balance Sheet > short Term Investments
-
Quarters > 0 > balance Sheet > receivables
1510015
Quarters > 0 > balance Sheet > inventories
4482304
Quarters > 0 > balance Sheet > total Current Assets
15724321
Quarters > 0 > balance Sheet > property Plant Equipment
432797
Quarters > 0 > balance Sheet > total Assets
-
Quarters > 0 > balance Sheet > payables
2780236
Quarters > 0 > balance Sheet > short Term Debt
-
Quarters > 0 > balance Sheet > long Term Debt
-
Quarters > 0 > balance Sheet > total Liabilities
10692129
Quarters > 0 > balance Sheet > equity
-
Quarters > 0 > balance Sheet > currency_symbol
NOK
Quarters > 0 > cash Flow > net Income
-4700596
Quarters > 0 > cash Flow > depreciation
227800
Quarters > 0 > cash Flow > change In Working Capital
-
Quarters > 0 > cash Flow > cash From Operations
-5552208
Quarters > 0 > cash Flow > capital Expenditures
0
Quarters > 0 > cash Flow > cash From Investing
-2702670
Quarters > 0 > cash Flow > cash From Financing
10406301
Quarters > 0 > cash Flow > net Change In Cash
2151424
Quarters > 0 > cash Flow > currency_symbol
NOK
Quarters > 0 > ratios > PE
-
Quarters > 0 > ratios > PB
-
Quarters > 0 > ratios > ROE
-
Quarters > 0 > ratios > ROA
-
Quarters > 0 > ratios > FCF
-5552208
Quarters > 0 > ratios > Piotroski FScore
0
Quarters > 0 > ratios > fcf Percent
-
Quarters > 0 > health Score
45
Quarters > 1 > quarter
2021-03-31
Quarters > 1 > income Statement > revenue
-
Quarters > 1 > income Statement > cost Of Revenue
-
Quarters > 1 > income Statement > gross Profit
-
Quarters > 1 > income Statement > operating Expenses
-
Quarters > 1 > income Statement > operating Income
-
Quarters > 1 > income Statement > interest Expense
-
Quarters > 1 > income Statement > pretax Income
-
Quarters > 1 > income Statement > net Income
-
Quarters > 1 > income Statement > eps
-
Quarters > 1 > income Statement > dividends Per Share
-
Quarters > 1 > income Statement > shares Outstanding
-
Quarters > 1 > income Statement > income Tax Expense
-
Quarters > 1 > income Statement > EBITDA
-
Quarters > 1 > income Statement > operating Margin
-
Quarters > 1 > income Statement > total Other Income Expense Net
-
Quarters > 1 > income Statement > currency_symbol
NOK
Quarters > 1 > balance Sheet > cash
-
Quarters > 1 > balance Sheet > short Term Investments
-
Quarters > 1 > balance Sheet > receivables
1510015
Quarters > 1 > balance Sheet > inventories
4482304
Quarters > 1 > balance Sheet > total Current Assets
15724321
Quarters > 1 > balance Sheet > property Plant Equipment
432797
Quarters > 1 > balance Sheet > total Assets
-
Quarters > 1 > balance Sheet > payables
2780236
Quarters > 1 > balance Sheet > short Term Debt
-
Quarters > 1 > balance Sheet > long Term Debt
-
Quarters > 1 > balance Sheet > total Liabilities
10692129
Quarters > 1 > balance Sheet > equity
-
Quarters > 1 > balance Sheet > currency_symbol
NOK
Quarters > 1 > cash Flow > net Income
-4700596
Quarters > 1 > cash Flow > depreciation
227800
Quarters > 1 > cash Flow > change In Working Capital
-
Quarters > 1 > cash Flow > cash From Operations
-5552208
Quarters > 1 > cash Flow > capital Expenditures
0
Quarters > 1 > cash Flow > cash From Investing
-2702670
Quarters > 1 > cash Flow > cash From Financing
10406301
Quarters > 1 > cash Flow > net Change In Cash
2151424
Quarters > 1 > cash Flow > currency_symbol
NOK
Quarters > 1 > ratios > PE
-
Quarters > 1 > ratios > PB
-
Quarters > 1 > ratios > ROE
-
Quarters > 1 > ratios > ROA
-
Quarters > 1 > ratios > FCF
-5552208
Quarters > 1 > ratios > Piotroski FScore
0
Quarters > 1 > ratios > fcf Percent
-
Quarters > 1 > health Score
45
Quarters > 2 > quarter
2020-06-30
Quarters > 2 > income Statement > revenue
-
Quarters > 2 > income Statement > cost Of Revenue
-
Quarters > 2 > income Statement > gross Profit
-
Quarters > 2 > income Statement > operating Expenses
-
Quarters > 2 > income Statement > operating Income
-
Quarters > 2 > income Statement > interest Expense
-
Quarters > 2 > income Statement > pretax Income
-
Quarters > 2 > income Statement > net Income
-
Quarters > 2 > income Statement > eps
-
Quarters > 2 > income Statement > dividends Per Share
-
Quarters > 2 > income Statement > shares Outstanding
-
Quarters > 2 > income Statement > income Tax Expense
-
Quarters > 2 > income Statement > EBITDA
-
Quarters > 2 > income Statement > operating Margin
-
Quarters > 2 > income Statement > total Other Income Expense Net
-
Quarters > 2 > income Statement > currency_symbol
NOK
Quarters > 2 > balance Sheet > cash
-
Quarters > 2 > balance Sheet > short Term Investments
-
Quarters > 2 > balance Sheet > receivables
2025623
Quarters > 2 > balance Sheet > inventories
-
Quarters > 2 > balance Sheet > total Current Assets
3652902
Quarters > 2 > balance Sheet > property Plant Equipment
396380
Quarters > 2 > balance Sheet > total Assets
-
Quarters > 2 > balance Sheet > payables
944022
Quarters > 2 > balance Sheet > short Term Debt
-
Quarters > 2 > balance Sheet > long Term Debt
-
Quarters > 2 > balance Sheet > total Liabilities
3135389
Quarters > 2 > balance Sheet > equity
-
Quarters > 2 > balance Sheet > currency_symbol
NOK
Quarters > 2 > cash Flow > net Income
-3204531
Quarters > 2 > cash Flow > depreciation
24555
Quarters > 2 > cash Flow > change In Working Capital
-
Quarters > 2 > cash Flow > cash From Operations
-3270694
Quarters > 2 > cash Flow > capital Expenditures
19995
Quarters > 2 > cash Flow > cash From Investing
-19995
Quarters > 2 > cash Flow > cash From Financing
666500
Quarters > 2 > cash Flow > net Change In Cash
-2624189
Quarters > 2 > cash Flow > currency_symbol
NOK
Quarters > 2 > ratios > PE
-
Quarters > 2 > ratios > PB
-
Quarters > 2 > ratios > ROE
-
Quarters > 2 > ratios > ROA
-
Quarters > 2 > ratios > FCF
-3290689
Quarters > 2 > ratios > Piotroski FScore
0
Quarters > 2 > ratios > fcf Percent
-
Quarters > 2 > health Score
45
Quarters > 3 > quarter
2020-03-31
Quarters > 3 > income Statement > revenue
-
Quarters > 3 > income Statement > cost Of Revenue
-
Quarters > 3 > income Statement > gross Profit
-
Quarters > 3 > income Statement > operating Expenses
-
Quarters > 3 > income Statement > operating Income
-
Quarters > 3 > income Statement > interest Expense
-
Quarters > 3 > income Statement > pretax Income
-
Quarters > 3 > income Statement > net Income
-
Quarters > 3 > income Statement > eps
-
Quarters > 3 > income Statement > dividends Per Share
-
Quarters > 3 > income Statement > shares Outstanding
-
Quarters > 3 > income Statement > income Tax Expense
-
Quarters > 3 > income Statement > EBITDA
-
Quarters > 3 > income Statement > operating Margin
-
Quarters > 3 > income Statement > total Other Income Expense Net
-
Quarters > 3 > income Statement > currency_symbol
NOK
Quarters > 3 > balance Sheet > cash
-
Quarters > 3 > balance Sheet > short Term Investments
-
Quarters > 3 > balance Sheet > receivables
2025623
Quarters > 3 > balance Sheet > inventories
-
Quarters > 3 > balance Sheet > total Current Assets
3652902
Quarters > 3 > balance Sheet > property Plant Equipment
396380
Quarters > 3 > balance Sheet > total Assets
-
Quarters > 3 > balance Sheet > payables
944022
Quarters > 3 > balance Sheet > short Term Debt
-
Quarters > 3 > balance Sheet > long Term Debt
-
Quarters > 3 > balance Sheet > total Liabilities
3135389
Quarters > 3 > balance Sheet > equity
-
Quarters > 3 > balance Sheet > currency_symbol
NOK
Quarters > 3 > cash Flow > net Income
-3204531
Quarters > 3 > cash Flow > depreciation
24555
Quarters > 3 > cash Flow > change In Working Capital
-
Quarters > 3 > cash Flow > cash From Operations
-3270694
Quarters > 3 > cash Flow > capital Expenditures
19995
Quarters > 3 > cash Flow > cash From Investing
-19995
Quarters > 3 > cash Flow > cash From Financing
666500
Quarters > 3 > cash Flow > net Change In Cash
-2624189
Quarters > 3 > cash Flow > currency_symbol
NOK
Quarters > 3 > ratios > PE
-
Quarters > 3 > ratios > PB
-
Quarters > 3 > ratios > ROE
-
Quarters > 3 > ratios > ROA
-
Quarters > 3 > ratios > FCF
-3290689
Quarters > 3 > ratios > Piotroski FScore
0
Quarters > 3 > ratios > fcf Percent
-
Quarters > 3 > health Score
45
Annuals > 0 > quarter
2019-12-31
Annuals > 0 > income Statement > revenue
-
Annuals > 0 > income Statement > cost Of Revenue
-
Annuals > 0 > income Statement > gross Profit
-
Annuals > 0 > income Statement > operating Expenses
-
Annuals > 0 > income Statement > operating Income
-
Annuals > 0 > income Statement > interest Expense
0
Annuals > 0 > income Statement > pretax Income
-
Annuals > 0 > income Statement > net Income
-
Annuals > 0 > income Statement > eps
-
Annuals > 0 > income Statement > dividends Per Share
-
Annuals > 0 > income Statement > shares Outstanding
-
Annuals > 0 > income Statement > income Tax Expense
-
Annuals > 0 > income Statement > EBITDA
-
Annuals > 0 > income Statement > operating Margin
-
Annuals > 0 > income Statement > total Other Income Expense Net
-
Annuals > 0 > income Statement > currency_symbol
NOK
Annuals > 0 > balance Sheet > cash
-
Annuals > 0 > balance Sheet > short Term Investments
-
Annuals > 0 > balance Sheet > receivables
947273
Annuals > 0 > balance Sheet > inventories
2157694
Annuals > 0 > balance Sheet > total Current Assets
9980623
Annuals > 0 > balance Sheet > property Plant Equipment
405500
Annuals > 0 > balance Sheet > total Assets
-
Annuals > 0 > balance Sheet > payables
786576
Annuals > 0 > balance Sheet > short Term Debt
-
Annuals > 0 > balance Sheet > long Term Debt
-
Annuals > 0 > balance Sheet > total Liabilities
3063167
Annuals > 0 > balance Sheet > equity
-
Annuals > 0 > balance Sheet > currency_symbol
NOK
Annuals > 0 > cash Flow > net Income
-13215518
Annuals > 0 > cash Flow > depreciation
120016
Annuals > 0 > cash Flow > change In Working Capital
-
Annuals > 0 > cash Flow > cash From Operations
-17194496
Annuals > 0 > cash Flow > capital Expenditures
17838
Annuals > 0 > cash Flow > cash From Investing
-17838
Annuals > 0 > cash Flow > cash From Financing
20706453
Annuals > 0 > cash Flow > net Change In Cash
3605598
Annuals > 0 > cash Flow > currency_symbol
NOK
Annuals > 0 > ratios > PE
-
Annuals > 0 > ratios > PB
-
Annuals > 0 > ratios > ROE
-
Annuals > 0 > ratios > ROA
-
Annuals > 0 > ratios > FCF
-17212334
Annuals > 0 > ratios > Piotroski FScore
0
Annuals > 0 > ratios > fcf Percent
-
Annuals > 0 > health Score
45
Annuals > 1 > quarter
2018-12-31
Annuals > 1 > income Statement > revenue
-
Annuals > 1 > income Statement > cost Of Revenue
-
Annuals > 1 > income Statement > gross Profit
-
Annuals > 1 > income Statement > operating Expenses
-
Annuals > 1 > income Statement > operating Income
-
Annuals > 1 > income Statement > interest Expense
0
Annuals > 1 > income Statement > pretax Income
-
Annuals > 1 > income Statement > net Income
-
Annuals > 1 > income Statement > eps
-
Annuals > 1 > income Statement > dividends Per Share
-
Annuals > 1 > income Statement > shares Outstanding
-
Annuals > 1 > income Statement > income Tax Expense
-
Annuals > 1 > income Statement > EBITDA
-
Annuals > 1 > income Statement > operating Margin
-
Annuals > 1 > income Statement > total Other Income Expense Net
-
Annuals > 1 > income Statement > currency_symbol
NOK
Annuals > 1 > balance Sheet > cash
-
Annuals > 1 > balance Sheet > short Term Investments
-
Annuals > 1 > balance Sheet > receivables
1271545
Annuals > 1 > balance Sheet > inventories
4733100
Annuals > 1 > balance Sheet > total Current Assets
9274703
Annuals > 1 > balance Sheet > property Plant Equipment
507680
Annuals > 1 > balance Sheet > total Assets
-
Annuals > 1 > balance Sheet > payables
1209933
Annuals > 1 > balance Sheet > short Term Debt
-
Annuals > 1 > balance Sheet > long Term Debt
-
Annuals > 1 > balance Sheet > total Liabilities
10132441
Annuals > 1 > balance Sheet > equity
-
Annuals > 1 > balance Sheet > currency_symbol
NOK
Annuals > 1 > cash Flow > net Income
-38466070
Annuals > 1 > cash Flow > depreciation
780069
Annuals > 1 > cash Flow > change In Working Capital
-
Annuals > 1 > cash Flow > cash From Operations
-17227016
Annuals > 1 > cash Flow > capital Expenditures
17219
Annuals > 1 > cash Flow > cash From Investing
-358435
Annuals > 1 > cash Flow > cash From Financing
-983349
Annuals > 1 > cash Flow > net Change In Cash
-18545026
Annuals > 1 > cash Flow > currency_symbol
NOK
Annuals > 1 > ratios > PE
-
Annuals > 1 > ratios > PB
-
Annuals > 1 > ratios > ROE
-
Annuals > 1 > ratios > ROA
-
Annuals > 1 > ratios > FCF
-17244235
Annuals > 1 > ratios > Piotroski FScore
0
Annuals > 1 > ratios > fcf Percent
-
Annuals > 1 > health Score
45
Annuals > 2 > quarter
2017-12-31
Annuals > 2 > income Statement > revenue
-
Annuals > 2 > income Statement > cost Of Revenue
-
Annuals > 2 > income Statement > gross Profit
-
Annuals > 2 > income Statement > operating Expenses
-
Annuals > 2 > income Statement > operating Income
-
Annuals > 2 > income Statement > interest Expense
0
Annuals > 2 > income Statement > pretax Income
-
Annuals > 2 > income Statement > net Income
-
Annuals > 2 > income Statement > eps
-
Annuals > 2 > income Statement > dividends Per Share
6224975
Annuals > 2 > income Statement > shares Outstanding
-
Annuals > 2 > income Statement > income Tax Expense
1247369
Annuals > 2 > income Statement > EBITDA
-
Annuals > 2 > income Statement > operating Margin
-
Annuals > 2 > income Statement > total Other Income Expense Net
-
Annuals > 2 > income Statement > currency_symbol
NOK
Annuals > 2 > balance Sheet > cash
-
Annuals > 2 > balance Sheet > short Term Investments
-
Annuals > 2 > balance Sheet > receivables
1938123
Annuals > 2 > balance Sheet > inventories
20593565
Annuals > 2 > balance Sheet > total Current Assets
44346770
Annuals > 2 > balance Sheet > property Plant Equipment
617926
Annuals > 2 > balance Sheet > total Assets
-
Annuals > 2 > balance Sheet > payables
1273551
Annuals > 2 > balance Sheet > short Term Debt
-
Annuals > 2 > balance Sheet > long Term Debt
-
Annuals > 2 > balance Sheet > total Liabilities
9893478
Annuals > 2 > balance Sheet > equity
-
Annuals > 2 > balance Sheet > currency_symbol
NOK
Annuals > 2 > cash Flow > net Income
-16058852
Annuals > 2 > cash Flow > depreciation
792500
Annuals > 2 > cash Flow > change In Working Capital
-
Annuals > 2 > cash Flow > cash From Operations
-16362012
Annuals > 2 > cash Flow > capital Expenditures
24634
Annuals > 2 > cash Flow > cash From Investing
-935501
Annuals > 2 > cash Flow > cash From Financing
-7058393
Annuals > 2 > cash Flow > net Change In Cash
-24382862
Annuals > 2 > cash Flow > currency_symbol
NOK
Annuals > 2 > ratios > PE
-
Annuals > 2 > ratios > PB
-
Annuals > 2 > ratios > ROE
-
Annuals > 2 > ratios > ROA
-
Annuals > 2 > ratios > FCF
-16386646
Annuals > 2 > ratios > Piotroski FScore
0
Annuals > 2 > ratios > fcf Percent
-
Annuals > 2 > health Score
45
Annuals > 3 > quarter
2016-12-31
Annuals > 3 > income Statement > revenue
-
Annuals > 3 > income Statement > cost Of Revenue
-
Annuals > 3 > income Statement > gross Profit
-
Annuals > 3 > income Statement > operating Expenses
-
Annuals > 3 > income Statement > operating Income
-
Annuals > 3 > income Statement > interest Expense
0
Annuals > 3 > income Statement > pretax Income
-
Annuals > 3 > income Statement > net Income
-
Annuals > 3 > income Statement > eps
-
Annuals > 3 > income Statement > dividends Per Share
9979740
Annuals > 3 > income Statement > shares Outstanding
-
Annuals > 3 > income Statement > income Tax Expense
770183
Annuals > 3 > income Statement > EBITDA
-
Annuals > 3 > income Statement > operating Margin
-
Annuals > 3 > income Statement > total Other Income Expense Net
-
Annuals > 3 > income Statement > currency_symbol
NOK
Annuals > 3 > balance Sheet > cash
-
Annuals > 3 > balance Sheet > short Term Investments
-
Annuals > 3 > balance Sheet > receivables
949531
Annuals > 3 > balance Sheet > inventories
15300000
Annuals > 3 > balance Sheet > total Current Assets
64950478
Annuals > 3 > balance Sheet > property Plant Equipment
719503
Annuals > 3 > balance Sheet > total Assets
-
Annuals > 3 > balance Sheet > payables
790889
Annuals > 3 > balance Sheet > short Term Debt
-
Annuals > 3 > balance Sheet > long Term Debt
-
Annuals > 3 > balance Sheet > total Liabilities
8317027
Annuals > 3 > balance Sheet > equity
-
Annuals > 3 > balance Sheet > currency_symbol
NOK
Annuals > 3 > cash Flow > net Income
1462198
Annuals > 3 > cash Flow > depreciation
3928754
Annuals > 3 > cash Flow > change In Working Capital
-
Annuals > 3 > cash Flow > cash From Operations
25790065
Annuals > 3 > cash Flow > capital Expenditures
58003
Annuals > 3 > cash Flow > cash From Investing
-408259
Annuals > 3 > cash Flow > cash From Financing
-20490078
Annuals > 3 > cash Flow > net Change In Cash
4202261
Annuals > 3 > cash Flow > currency_symbol
NOK
Annuals > 3 > ratios > PE
-
Annuals > 3 > ratios > PB
-
Annuals > 3 > ratios > ROE
-
Annuals > 3 > ratios > ROA
-
Annuals > 3 > ratios > FCF
25732062
Annuals > 3 > ratios > Piotroski FScore
1
Annuals > 3 > ratios > fcf Percent
-
Annuals > 3 > health Score
46
Valuation > final Score
50
Valuation > verdict
Fair
Profitability > final Score
50
Profitability > verdict
Weak
Risk > final Score
50
Risk > verdict
High
Liquidity > metrics > Current Ratio
5.6557504470843485
Liquidity > metrics > Quick Ratio
4.043547741990248
Liquidity > final Score
100
Liquidity > verdict
Great
Prev Valuations > 0
50
Prev Valuations > 1
50
Prev Valuations > 2
50
Prev Profitabilities > 0
50
Prev Profitabilities > 1
50
Prev Profitabilities > 2
50
Prev Risks > 0
50
Prev Risks > 1
50
Prev Risks > 2
50
Prev Liquidities > 0
100
Prev Liquidities > 1
100
Prev Liquidities > 2
100
Updated At
2026-01-20T23:13:34.712Z
Earnings History > 0 > period
2015-12-31
Earnings History > 0 > report Date
2015-12-31
Earnings History > 0 > date
2015-12-31
Earnings History > 0 > before After Market
-
Earnings History > 0 > currency
NOK
Earnings History > 0 > eps Actual
0.6648
Earnings History > 0 > eps Estimate
-
Earnings History > 0 > eps Difference
0
Earnings History > 0 > surprise Percent
-
Earnings History > 1 > period
2015-09-30
Earnings History > 1 > report Date
2015-09-30
Earnings History > 1 > date
2015-09-30
Earnings History > 1 > before After Market
-
Earnings History > 1 > currency
NOK
Earnings History > 1 > eps Actual
0.3791
Earnings History > 1 > eps Estimate
-
Earnings History > 1 > eps Difference
0
Earnings History > 1 > surprise Percent
-
Aqua Bio Technology ASA, a biotechnology company, commercializes ingredients for cosmetics in Norway. It offers Aquabeautine XL, a first-generation ingredient for cosmetics; and Spirulysat, an antioxidant and vitamin-boosted spirulina for cosmetic use, as well as has license for Zand Exfoliator. The company also markets skincare products, such as toner, serum, renewal day cream, oil, nourishing cream, night repair serum, night repair complex moisturizer, make-up remover, instant lifting mask, gentle exfoliator, eye firming, and gel cleansing milk under the Moana Skincare brand; serum and moisturizer under the Tau brand name; and protecting balm, oil, lotion, and calming cream under the Moana Baby brand through a network of distributors in Europe, the Middle East, and the Asia Pacific markets. In addition, the company offers askincare products under the seidr, seidr Clinique, and B Natural brands. It distributes its products through Internet, stores, and skincare clinics. Aqua Bio Technology ASA was founded in 2000 and is based in Lysaker, Norway.
Stock Price
NOK0.00
increase compared to yesterday.
Dividend
Frequency:
Rate:
N/ANext Payout:
N/A(Last Updated 2021-06-30)
Health Score
* Institutions hold a combined 0.00% of the total shares of Aqua Bio Technology ASA
* Investors data is estimated based on stocks listed on Finnton that are currently held by Institution/Fund.
Date
—
EPS Estimate
—
Date
2015-12-31
EPS Actual
0.6648
EPS Estimate
—
EPS Difference
0
Surprise Percent
0%
(Last Updated 2021-06-30)
(Last Updated 2021-06-30)
Revenue
NOK 0
Cost Of Revenue
NOK 0
Gross Profit
NOK 0
Operating Expenses
NOK 0
Operating Income
NOK 0
Interest Expense
NOK 0
Pretax Income
NOK 0
Net Income
NOK 0
Income Tax Expense
NOK 0
EBITDA
NOK 0
Total Other Income Expense Net
NOK 0
Earnings Per Share
0
Dividends Per Share
0
Shares Outstanding
0
Operating Margin
0%
(Last Updated 2021-06-30)
Cash
NOK 0
Short Term Investments
NOK 0
Receivables
NOK 0
Inventories
NOK 0
Total Current Assets
NOK 0
Property Plant Equipment
NOK 0
Total Assets
NOK 0
Payables
NOK 0
Short Term Debt
NOK 0
Long Term Debt
NOK 0
Total Liabilities
NOK 0
Equity
NOK 0
(Last Updated 2021-06-30)
Net Income
NOK 0
Depreciation
NOK 0
Change In Working Capital
NOK 0
Cash From Operations
NOK 0
Capital Expenditures
NOK 0
Cash From Investing
NOK 0
Cash From Financing
NOK 0
Net Change In Cash
NOK 0
Disclaimer: Finnton is a stock screener tool provided for informational and educational purposes only. The data, analysis, and insights offered on this website do not constitute financial, investment, tax, or legal advice. Users are solely responsible for their own investment decisions, and Finnton makes no guarantees regarding the accuracy, completeness, or reliability of the information provided. Past performance is not indicative of future results. Always conduct your own research and consult with a licensed financial advisor before making any investment decisions.